These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29486328)

  • 21. Breaching barriers in glioblastoma. Part II: Targeted drug delivery and lipid nanoparticles.
    Miranda A; Blanco-Prieto MJ; Sousa J; Pais A; Vitorino C
    Int J Pharm; 2017 Oct; 531(1):389-410. PubMed ID: 28801108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
    Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
    Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.
    Pinheiro M; Ribeiro R; Vieira A; Andrade F; Reis S
    Drug Des Devel Ther; 2016; 10():2467-75. PubMed ID: 27536067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-moduline.
    Kuo YC; Hong TY
    Int J Pharm; 2014 Apr; 465(1-2):132-42. PubMed ID: 24524828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticles: Novel vehicles in treatment of Glioblastoma.
    Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M
    Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier.
    Monaco I; Camorani S; Colecchia D; Locatelli E; Calandro P; Oudin A; Niclou S; Arra C; Chiariello M; Cerchia L; Comes Franchini M
    J Med Chem; 2017 May; 60(10):4510-4516. PubMed ID: 28471660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unstructured Formulation Data Analysis for the Optimization of Lipid Nanoparticle Drug Delivery Vehicles.
    Silva J; Mendes M; Cova T; Sousa J; Pais A; Vitorino C
    AAPS PharmSciTech; 2018 Jul; 19(5):2383-2394. PubMed ID: 29869314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Advances in the Use of Lipid-Based Nanoparticles Against Glioblastoma Multiforme.
    Ortega-Berlanga B; Gonzalez C; Navarro-Tovar G
    Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):8. PubMed ID: 33772646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oil-enriched, ultra-small nanostructured lipid carriers (usNLC): a novel delivery system based on flip-flop structure.
    Keck CM; Baisaeng N; Durand P; Prost M; Meinke MC; Müller RH
    Int J Pharm; 2014 Dec; 477(1-2):227-35. PubMed ID: 25455773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.
    Peiris PM; Abramowski A; Mcginnity J; Doolittle E; Toy R; Gopalakrishnan R; Shah S; Bauer L; Ghaghada KB; Hoimes C; Brady-Kalnay SM; Basilion JP; Griswold MA; Karathanasis E
    Cancer Res; 2015 Apr; 75(7):1356-65. PubMed ID: 25627979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of disulfiram-loaded poly(lactic-co-glycolic acid) wafers for the localised treatment of glioblastoma multiforme: a comparison of manufacturing techniques.
    Zembko I; Ahmed I; Farooq A; Dail J; Tawari P; Wang W; Mcconville C
    J Pharm Sci; 2015 Mar; 104(3):1076-86. PubMed ID: 25537972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
    Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
    J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
    Kim SS; Harford JB; Pirollo KF; Chang EH
    Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.
    Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J
    Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A two-pronged approach against glioblastoma: drug repurposing and nanoformulation design for in situ-controlled release.
    Mendes M; Branco F; Vitorino R; Sousa J; Pais A; Vitorino C
    Drug Deliv Transl Res; 2023 Dec; 13(12):3169-3191. PubMed ID: 37574500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug delivery approaches for the treatment of glioblastoma multiforme.
    Fakhoury M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
    Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
    J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-density lipoprotein-biomimetic nanocarriers for glioblastoma-targeting delivery: the effect of shape.
    Huang JL; Jiang G; Song QX; Gu X; Song HH; Wang XL; Jiang D; Kang T; Feng XY; Jiang XG; Chen HZ; Gao XL
    Pharmazie; 2016 Dec; 71(12):709-714. PubMed ID: 29441999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.
    Dhami NK; Pandey RS; Jain UK; Chandra R; Madan J
    J Microencapsul; 2014; 31(7):685-93. PubMed ID: 24963955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.